In a report released yesterday, Leland Gershell from Oppenheimer assigned a Buy rating to CASI Pharmaceuticals (CASI), with a price target of $5.00.
The post Oppenheimer Thinks CASI Pharmaceuticals Stock is Going to Recover appeared first on Smarter Analyst.
In a report released yesterday, Leland ...

https://www.smarteranalyst.com/new-blurbs/oppenheimer-thinks-casi-pharmaceuticals-stock-is-going-to-recover/

#SmarterAnalyst